Newronika, Receives

Newronika Receives CE Mark Approval for AlphaDBS, Advancing Adaptive Deep Brain Stimulation for Parkinson's Disease

Veröffentlicht: 07.08.2025 um 18:06 Uhr, prnewswire.co.uk

Newronika Germany Austria United Kingdom United States of America France Spain Italy New York Europe California

or follow us on LinkedIn.

Logo - https://mma.prnewswire.com/media/2612569/5150136/Newronika_Logo.jpg

Contact
Michael Fattore
CFO
+39 02 84109381
info@newronika.com 

Cision View original content:https://www.prnewswire.co.uk/news-releases/newronika-receives-ce-mark-approval-for-alphadbs-advancing-adaptive-deep-brain-stimulation-for-parkinsons-disease-302408082.html

en | boerse | 67951480 |